Search

Yishai Zohar

from Brookline, MA
Age ~59

Yishai Zohar Phones & Addresses

  • Brookline, MA
  • 134 Vine St, Chestnut Hill, MA 02467 (617) 795-0264 (617) 916-5045 (617) 916-5046
  • Boston, MA
  • Medfield, MA
  • Port Allegany, PA
  • Washington, AR
  • Newton Center, MA

Work

Company: Endra life sciences (nasdaq: ndra) 2009 to 2013 Position: Director

Skills

Start Ups • Biotechnology • R&D • Venture Capital • Entrepreneurship • Technology Transfer • Life Sciences • Pharmaceutical Industry • Strategy • Management • Business Development • Lifesciences • New Business Development • Commercialization • Product Development • Medical Devices • Business Strategy • Due Diligence • Research and Development

Industries

Biotechnology

Resumes

Resumes

Yishai Zohar Photo 1

Chief Executive Officer And Founder

View page
Location:
Boston, MA
Industry:
Biotechnology
Work:
Endra Life Sciences (Nasdaq: Ndra) 2009 - 2013
Director

Gelesis 2009 - 2013
Chief Executive Officer and Founder

Puretech Health 2001 - 2006
Co-Founder
Skills:
Start Ups
Biotechnology
R&D
Venture Capital
Entrepreneurship
Technology Transfer
Life Sciences
Pharmaceutical Industry
Strategy
Management
Business Development
Lifesciences
New Business Development
Commercialization
Product Development
Medical Devices
Business Strategy
Due Diligence
Research and Development

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yishai Zohar
President
GELESIS 2012, INC
500 Boylston St STE 1600, Boston, MA 02116
Yishai Zohar
Director
ENDRA INC
500 Boylston St, Boston, MA 02116
Yishai Zohar
Manager
KALILA, LLC
79 Chandler St UNIT 9, Boston, MA 02116
Yishai Zohar
Chief Executive Officer Of Gelesis Puretech Co-founder, Chief Executive Officer And Director
PureTech Health
Biotechnology · Investment Advisory Service
500 Boylston St, Boston, MA 02116
222 Berkeley St, Boston, MA 02116
(617) 482-2333
Yishai Zohar
President, Founder
GELESIS, INC
Commercial Physical Research
500 Boylston St, Boston, MA 02116
222 Berkeley St, Boston, MA 02116

Publications

Us Patents

Methods Of Purifying Poly(Styrene-Co-Maleic Anhydride/Acid)

View page
US Patent:
20110021729, Jan 27, 2011
Filed:
Mar 19, 2010
Appl. No.:
12/727371
Inventors:
Eyal S. Ron - Lexington MA, US
Yishai Zohar - Boston MA, US
Barry J. Hand - Acton MA, US
Mircea Dan Bucevschi - Rehovot, IL
Monica Colt - Rehovot, IL
International Classification:
C08F 222/08
C08F 222/02
C08F 6/12
US Classification:
526272, 52631825
Abstract:
The present invention relates in part to poly(styrene-co-maleic anhydride/acid) copolymers having high purity, for example, having low amounts of maleic acid, maleic anhydride, and/or styrene. The present invention also relates in parts to methods of purifying poly(styrene-co-maleic anhydride/acid) copolymers to remove the residual monomers and low molecular weight fragments.

Methods And Compositions For Weight Management And For Improving Glycemic Control

View page
US Patent:
20120052151, Mar 1, 2012
Filed:
May 13, 2011
Appl. No.:
13/106909
Inventors:
Alessandro Sannino - Lecce, IT
Luigi Ambrosio - Ottaviano, IT
Eyal S. Ron - Lexington MA, US
Yishai Zohar - Boston MA, US
International Classification:
A23L 1/307
A23L 2/52
A23L 1/10
A21D 13/00
A23L 1/16
A23L 1/0534
A21D 13/08
US Classification:
426 2, 426573, 426 96
Abstract:
The present invention provides methods, compositions and modified foods and foodstuffs useful for weight management and glycemic control.

Method For Producing Hydrogels

View page
US Patent:
20130089737, Apr 11, 2013
Filed:
Jun 7, 2012
Appl. No.:
13/491197
Inventors:
Alessandro Sannino - Lecce, IT
Christian Demitri - San Pietro In Lama, IT
Yishai Zohar - Boston MA, US
Barry Joseph Hand - Acton MA, US
Eyal S. Ron - Lexington MA, US
International Classification:
C08B 3/12
US Classification:
428402, 536 63
Abstract:
The present invention provides a method of producing a polymer hydrogel comprising the steps of: (1) preparing an aqueous solution of a water soluble polysaccharide derivative and a polycarboxylic acid; (2) optionally agitating the solution, for example, by stirring; (3) isolating a polysaccharide derivative/polycarboxylic acid composite from the solution; and (4) heating the polysaccharide derivative/polycarboxylic acid composite at a temperature of at least about 80° C., thereby cross-linking the polysaccharide with the polycarboxylic acid. The invention also provides polymer hydrogels produced by the methods of the invention.

Use Of Polymeric Materials With Other Substances For Improved Performance

View page
US Patent:
20090311235, Dec 17, 2009
Filed:
Mar 13, 2009
Appl. No.:
12/403788
Inventors:
Eric Elenko - Boston MA, US
Eyal S. Ron - Lexington MA, US
Yishai Zohar - Boston MA, US
International Classification:
A61K 38/48
A61K 33/08
A61K 33/10
A61K 31/4439
A61K 31/426
A61K 31/4188
A61K 31/4164
A61K 31/365
A61K 31/341
A61K 31/135
A61K 31/137
A61P 11/00
A61P 3/00
A61P 25/00
US Classification:
424 9421, 424 9466, 424682, 424686, 424687, 514338, 514365, 514370, 514393, 514400, 514449, 514471, 514650, 514654, 5147723
Abstract:
Methods of enabling or improving the ability of a hydrogel to swell in the stomach of an animal and/or increasing the amount of time said hydrogel remains swollen in the stomach are described herein. In one embodiment, a polymer is administered in combination with one or more pH modifying agents which raise and maintain the pH of the micro environment of the polymer and/or the stomach in order inducing swelling in the polymer. The polymer can be a homopolymer, a copolymer, or a polymer blend or composite. In one embodiment, the polymer is a superabsorbent polymer (“SAP”). The polymers can also be administered with one or more active agents, such as appetite suppressants. The pH modifying agent and/or the active agent can be administered simultaneously with the polymer in the same dosage form, simultaneously with the polymer in separate dosage forms, or sequentially. The compositions are formulated for oral administration. The formulation can include drugs for delivery to the stomach, such as antibiotics, or the hydrogel can be used as a filler, for example, for obesity control. The formulation an also be used to enhance gastric retention, for example, for controlled drug delivery. Methods of delivering a drug are also described herein, along with medicaments for carrying out the methods of the present invention.
Yishai Zohar from Brookline, MA, age ~59 Get Report